David Bibi

3PUBLICATIONS
5CO-AUTHORS
Pharmaceutical delivery technologiesAircraft performance and flight control systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 27, 2026
Olanzapine for Extended-Release Injectable Suspension for Subcutaneous Use (TV-44749) Designed to Avoid the Risk of PDSS: In Vitro Release Studies in Human Plasma and In Vivo Impact of Extrinsic Factors on Pharmacokinetics.

|Feb 26, 2025
An Evaluation of the Subcutaneous Depot Release of TV-46000, A Novel Long-Acting Injectable (LAI) Formulation of Risperidone, Under Extreme Conditions in Dogs, Minipigs and Humans.

Lilach Steiner, David Bibi, Avia Merenlender Wagner

|Jul 27, 2024
Physiologically-Based Pharmacokinetic Modeling and In Vitro-In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human.

David Bibi, Raphael Bilgraer, Lilach Steiner

Pageof 1

Frequent Collaborators

3 joint publications

Hussein Hallak

1 joint publications

Iva Krtalic

1 joint publications

Marina Juretic

1 joint publications

Biserka Cetina-Cizmek